SENEXON-S (NCS HealthCare of KY, Inc dba Vangard Labs)
Welcome to the PulseAid listing for the SENEXON-S drug offered from NCS HealthCare of KY, Inc dba Vangard Labs. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | NCS HealthCare of KY, Inc dba Vangard Labs |
NON-PROPRIETARY NAME: | docusate sodium-sennosides tablet |
SUBSTANCE NAME: | SENNOSIDES A AND B; DOCUSATE SODIUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, COATED |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2006-02-09 |
END MARKETING DATE: | 0000-00-00 |
SENEXON-S HUMAN OTC DRUG Details:
Item Description | SENEXON-S from NCS HealthCare of KY, Inc dba Vangard Labs |
LABELER NAME: | NCS HealthCare of KY, Inc dba Vangard Labs |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8.6; 50(mg/1; mg/1) |
START MARKETING DATE: | 2006-02-09 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0615-7773_7769018d-0184-4e86-b09b-e7ae38addfe5 |
PRODUCT NDC: | 0615-7773 |
APPLICATION NUMBER: | part334 |
Other SENNOSIDES A AND B; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers: